Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068764
Filing Date
2014-11-14
Accepted
2014-11-14 16:07:40
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v392799_10q.htm 10-Q 483374
2 EXHIBIT 31.1 v392799_ex31-1.htm EX-31.1 7542
3 EXHIBIT 31.2 v392799_ex31-2.htm EX-31.2 7463
4 EXHIBIT 32.1 v392799_ex32-1.htm EX-32.1 3794
5 EXHIBIT 32.2 v392799_ex32-2.htm EX-32.2 3965
  Complete submission text file 0001144204-14-068764.txt   6667861

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arni-20140930.xml EX-101.INS 1369235
7 XBRL TAXONOMY EXTENSION SCHEMA arni-20140930.xsd EX-101.SCH 58184
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20140930_cal.xml EX-101.CAL 21395
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20140930_def.xml EX-101.DEF 257440
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20140930_lab.xml EX-101.LAB 369590
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20140930_pre.xml EX-101.PRE 292547
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52153 | Film No.: 141224099
SIC: 2834 Pharmaceutical Preparations